They have shown that activated DNA-PKcs positively correlated with HCC proliferation, genomic instability and microvessel density, and negatively with apoptosis and patients’ survival, and these effects were counteracted by DNA-PKcs silencing12. The gene discussed is PRKDC; the disease is hepatocellular carcinoma.